Katherine Eban's book 'Bottle of Lies', about the 2004 Ranbaxy scandal, paints whole of Indian pharma as being unreliable, which is dangerous & biased.
India has one doctor for every 1,453 people as against the WHO recommended ratio of 1:1000 while its public spending on health is among the lowest in the world.
The recently published Global Wellness Index set alarm bells ringing when South Africa scored poorly for life expectancy, alcohol use, depression and diabetes.
Indian govt officials last month skipped Turkish National Day celebrations in Delhi, in a message to Ankara following its support for Islamabad, particularly during Operation Sindoor.
Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.
Katherine Eban and Kiran Mazumdar Shaw have one fundamental distinction: only one of them has a vested interest in the Indian generics industry. Readers can decide for themselves whom to believe.
corporate ambassador ;; what is ambassador job tell lies convincingly about its employer/client
I’ve read the entire book and don’t agree with Dr Kiran Mazumdar Shaw’s facile conclusion. Yes the bulk of the book is about Rambaxy and events more than 10 years old but it’s the all pervasive culture of ‘profit’ before ‘patients’ and widespread deep-rooted systemic dishonesty the author brings out. There’s nothing to suggest that has changed. And companies like Dr Reddy’s, Wockhardt, Zydus, GVS don’t exactly come out smelling of roses. It’s cold comfort that China is probably just as bad. We can either dismiss the book as motivated unsubstantiated propaganda or do some serious introspection. Pharma sector leaders like Dr Kiran Mazumdar Shaw need to take a proactive rather than defensive role. Mine, her and her mother’s lives may literally depend on that.
Kiran Mazumdar Shaw’s criticism of Katherine Eban’s book “Bottle of Lies” is totally unwarranted and completely unfair. I’ve read the full book and I agree with Katherine Eban on every point elaborated in the book. Contrary to what Kiran Mazumdar Shaw alleges, nothing in the book is anecdotal ― every fact in the narrative of the book is deeply researched and completely documented (see the 49 pages of “Notes” at the end of the book, with extensive links to documents available in public domain).
I agree that the protagonist in the book is Ranbaxy, but the theme is rampant data manipulation in Indian pharma industry with several examples including Wockhardt. The fact that nothing seems to have changed since the infamous days of Ranbaxy is evident even today. As recent as yesterday, USFDA found significant violations in Strides Pharma which led to its stock price plummeting 8%.
To be fair, Katherine Eban has very generously praised Cipla and it’s founder Dr Khwaja Abdul Hamied and his son for carrying the original vision of the generic drugs movement.
Indians do not like deep reseach which brings out much from underneath . first reaction deny and lase we are investgating samle ;;; IL 7 FS Dewan housing , ICICI,
There is no doubt of amazing contribution in health care system by developing generic and active materials. Played well
Pharmaceuticals is in fact one industry in which India has a long term competitive advantage. The government should assist it to reach global norms, taking care to avoid what happened to Ranbaxy. As cost of healthcare becomes a universal concern, India’s pharmaceutical industry can look forward to sustained growth.
If all that about generic drug makers wasn’t true why would unannounced checks by US drug Inspectors find so many faults in our companies and they didnt object they asked for time to get it corrected they could have challenged the fault pointed out.
Our drug Inspectors dont do any surprise checks, if they did perhaps the World would have greater faith in our generic drugs.
Chins too was found not being honest in their manufacture.
Recently n eye doctor pointed the difference in prescribed eye drops for his patients and the generic one which caused irritation and redness .Patients can tell the difference, what more proof does one need.
Katherine Eban and Kiran Mazumdar Shaw have one fundamental distinction: only one of them has a vested interest in the Indian generics industry. Readers can decide for themselves whom to believe.
corporate ambassador ;; what is ambassador job tell lies convincingly about its employer/client
I’ve read the entire book and don’t agree with Dr Kiran Mazumdar Shaw’s facile conclusion. Yes the bulk of the book is about Rambaxy and events more than 10 years old but it’s the all pervasive culture of ‘profit’ before ‘patients’ and widespread deep-rooted systemic dishonesty the author brings out. There’s nothing to suggest that has changed. And companies like Dr Reddy’s, Wockhardt, Zydus, GVS don’t exactly come out smelling of roses. It’s cold comfort that China is probably just as bad. We can either dismiss the book as motivated unsubstantiated propaganda or do some serious introspection. Pharma sector leaders like Dr Kiran Mazumdar Shaw need to take a proactive rather than defensive role. Mine, her and her mother’s lives may literally depend on that.
Kiran Mazumdar Shaw’s criticism of Katherine Eban’s book “Bottle of Lies” is totally unwarranted and completely unfair. I’ve read the full book and I agree with Katherine Eban on every point elaborated in the book. Contrary to what Kiran Mazumdar Shaw alleges, nothing in the book is anecdotal ― every fact in the narrative of the book is deeply researched and completely documented (see the 49 pages of “Notes” at the end of the book, with extensive links to documents available in public domain).
I agree that the protagonist in the book is Ranbaxy, but the theme is rampant data manipulation in Indian pharma industry with several examples including Wockhardt. The fact that nothing seems to have changed since the infamous days of Ranbaxy is evident even today. As recent as yesterday, USFDA found significant violations in Strides Pharma which led to its stock price plummeting 8%.
To be fair, Katherine Eban has very generously praised Cipla and it’s founder Dr Khwaja Abdul Hamied and his son for carrying the original vision of the generic drugs movement.
Indians do not like deep reseach which brings out much from underneath . first reaction deny and lase we are investgating samle ;;; IL 7 FS Dewan housing , ICICI,
There is no doubt of amazing contribution in health care system by developing generic and active materials. Played well
Pharmaceuticals is in fact one industry in which India has a long term competitive advantage. The government should assist it to reach global norms, taking care to avoid what happened to Ranbaxy. As cost of healthcare becomes a universal concern, India’s pharmaceutical industry can look forward to sustained growth.
If all that about generic drug makers wasn’t true why would unannounced checks by US drug Inspectors find so many faults in our companies and they didnt object they asked for time to get it corrected they could have challenged the fault pointed out.
Our drug Inspectors dont do any surprise checks, if they did perhaps the World would have greater faith in our generic drugs.
Chins too was found not being honest in their manufacture.
Recently n eye doctor pointed the difference in prescribed eye drops for his patients and the generic one which caused irritation and redness .Patients can tell the difference, what more proof does one need.